Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...
This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, ...
The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma boosted ...
Purdue Pharma LP’s Sackler family owners have joined a proposed settlement that would allow the OxyContin maker to exit bankruptcy and put more than $6 billion toward resolving opioid-related ...
FILE PHOTO: A pharmacist holds a bottle OxyContin made by Purdue Pharma at a pharmacy in Provo, Utah ...
Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...
(Reuters) -The Sackler family owners of Purdue Pharma are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits, while agreeing to some exposure to future ...
(Reuters) -The Sackler family owners of Purdue Pharma are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits, while agreeing to some exposure to future ...
The decision last month by the Harvard Corporation to retain Arthur M. Sackler's name on a museum building and second building runs counter to the trend among several institutions around the world ...
The decision last month by the Harvard Corporation to retain Arthur M. Sackler's name on a museum building and second building runs counter to the trend among several institutions around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback